MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) announced today that Noven scientists are presenting the results of four pre-clinical transdermal research projects today at the 2006 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. The full text of these poster presentations is available on Noven’s website at www.noven.com under “Research/Scientific Publications.”
